tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

KYMR Stock Latest News

Kymera Therapeutics Unveils 2025 Strategy and Trials
Company AnnouncementsKymera Therapeutics Unveils 2025 Strategy and Trials
17d ago
8K
KYMR
Kymera Therapeutics announces corporate goals for 2025
PremiumThe Fly
Kymera Therapeutics announces corporate goals for 2025
17d ago
KYMR
Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal
PremiumThe Fly
Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal
1M ago
JNJ
KYMR
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
PremiumThe Fly
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
1M ago
CAPR
GILD
Kymera Therapeutics initiated with a Buy at BTIG
PremiumThe Fly
Kymera Therapeutics initiated with a Buy at BTIG
2M ago
KYMR
Kymera Therapeutics initiated with a Market Perform at BMO Capital
PremiumThe FlyKymera Therapeutics initiated with a Market Perform at BMO Capital
2M ago
KYMR
Kymera Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
Premium
The Fly
Kymera Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
2M ago
KYMR
Kymera Therapeutics initiated with an Overweight at Stephens
Premium
The Fly
Kymera Therapeutics initiated with an Overweight at Stephens
2M ago
KYMR
Kymera Therapeutics price target raised to $49 from $45 at Morgan Stanley
PremiumThe Fly
Kymera Therapeutics price target raised to $49 from $45 at Morgan Stanley
3M ago
KYMR
Kymera Therapeutics price target raised to $52 from $45 at Guggenheim
PremiumThe Fly
Kymera Therapeutics price target raised to $52 from $45 at Guggenheim
3M ago
KYMR
U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
PremiumThe Fly
U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
3M ago
AZN
VIR
Kymera Therapeutics Reports Q3 2024 Earnings and Strategic Shift
PremiumCompany Announcements
Kymera Therapeutics Reports Q3 2024 Earnings and Strategic Shift
3M ago
KYMR
Kymera Therapeutics files automatic mixed securities shelf
PremiumThe FlyKymera Therapeutics files automatic mixed securities shelf
3M ago
KYMR
Kymera Therapeutics reports Q3 EPS (82c), consensus (84c)
Premium
The Fly
Kymera Therapeutics reports Q3 EPS (82c), consensus (84c)
3M ago
KYMR
Kymera doses first patient in Phase 1 trial of KT-621
Premium
The Fly
Kymera doses first patient in Phase 1 trial of KT-621
3M ago
KYMR
Kymera Therapeutics announces three presentations at EOTC-NI-AACR
PremiumThe Fly
Kymera Therapeutics announces three presentations at EOTC-NI-AACR
3M ago
KYMR
Kymera Therapeutics announces FDA clearance of IND application for KT-621
PremiumThe Fly
Kymera Therapeutics announces FDA clearance of IND application for KT-621
4M ago
KYMR
Kymera Therapeutics price target raised to $56 from $52 at Oppenheimer
PremiumThe Fly
Kymera Therapeutics price target raised to $56 from $52 at Oppenheimer
4M ago
KYMR
Kymera Therapeutics presents data for KT-621 at EADV Congress
PremiumThe Fly
Kymera Therapeutics presents data for KT-621 at EADV Congress
4M ago
KYMR
Kymera assumed with Outperform from Market Perform at Leerink
PremiumThe FlyKymera assumed with Outperform from Market Perform at Leerink
5M ago
KYMR
Boeing’s Starliner to return without astronauts: Morning Buzz
Premium
The Fly
Boeing’s Starliner to return without astronauts: Morning Buzz
5M ago
W
X
Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls
Premium
The Fly
Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls
5M ago
W
BJ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >